UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002557
Receipt No. R000003077
Scientific Title Multicenter randomized phase III study of adding Bevacizumab 5mg/kg or 10mg/kg to FOLFIRI in advanced colorectal cancer who have failed prior Bevacizumab plus Oxaliplatin-based therapy.
Date of disclosure of the study information 2009/09/30
Last modified on 2018/09/20 08:21:14

No. Disposal Last modified on Item of update
1 Insert 2009/09/28 19:38:46
2 Update 2010/03/29 18:52:05 Organization
Organization
3 Update 2010/08/24 13:25:00 Name of person sending information
Organization
Division name
Address
4 Update 2010/09/22 22:24:11 Public title
Acronym
Acronym
5 Update 2011/04/12 18:11:11 Target sample size
6 Update 2011/08/05 19:41:19 Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2012/02/01 15:09:50 Recruitment status
8 Update 2012/02/01 18:22:01 TEL
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
TEL
Organization1
Address1
Tel1
Email1
9 Update 2012/06/08 10:45:09 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Email1
10 Update 2012/08/29 12:59:54 Email
11 Update 2012/10/10 14:44:44 Email1
12 Update 2013/08/01 23:35:02 Last follow-up date
13 Update 2013/09/01 17:40:47 Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
14 Update 2013/11/15 18:22:12 Other related information
15 Update 2014/07/25 11:58:45 Results
Other related information
16 Update 2015/07/02 21:36:53 Recruitment status
Publication of results
Results
17 Update 2015/07/02 21:42:20 Results
Results
18 Update 2015/11/18 09:53:01 Recruitment status
Results
Other related information
19 Update 2016/04/04 16:03:47 Name of primary sponsor
Organization
20 Update 2018/09/20 08:21:14 Recruitment status


Contact us.